Etoricoxib tablets bulk supplier for pharma manufacturers

Etoricoxib Tablets 60 mg, 90 mg, 120 mg Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: 60 mg, 90 mg, 120 mg

Reference Brands: Arcoxia (EU)

Category: Arthritis

Etoricoxib selectively inhibits the COX-2 enzyme, reducing prostaglandin synthesis responsible for pain and inflammation. It provides effective relief in rheumatoid arthritis and osteoarthritis, with a lower risk of gastrointestinal side effects compared to non-selective NSAIDs. Benefits include rapid pain reduction, improved mobility, and better safety profile for long-term use.

Get Enquiry / Request Bulk Quote

Usually answered within 48 hours | GMP documents shared before you commit

Manufacture or export Etoricoxib Tablets? List it or send an offer →

Product Description: Etoricoxib tablets are approved in the EU for managing rheumatoid arthritis, osteoarthritis, and gout. In the EU, brands like Arcoxia are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and quality. In the US, etoricoxib is not approved by the FDA but is marketed in certain countries outside the US. Both regions require comprehensive dossiers for initial approval and ongoing pharmacovigilance. For expert assistance with regulatory dossiers, compliance, and registration, visit PharmaTradz. We support efficient market access for etoricoxib tablets, ensuring adherence to European standards for safe, effective pain and inflammation management.

Etoricoxib Tablets — third party manufacturing & bulk supply

Etoricoxib Tablets 60 mg, 90 mg, 120 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Etoricoxib Tablets is supplied as Tablets — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Etoricoxib Tablets listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Etoricoxib Tablets →

Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.

Back to Listing

Frequently Asked Questions

Etoricoxib tablets is listed as Tablets in 60 mg, 90 mg, 120 mg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Etoricoxib tablets is referenced against Arcoxia (EU). Reference brands are shown for identification only and remain the property of their respective trademark owners.